Stock fact sheet · data as of

Viemed Healthcare, Inc. (VMD): fair value, margin of safety and Wheel Score

Healthcare · Medical - Care Facilities · United States · High Growth

Close9.69
GLS fair value14.758 of 9 models
Margin of safety+34%price below fair value
Wheel Score77Goodout of 100
Health6/9Piotroski F-score
Moat6.9/10GLS 10-year score
Market cap$369M219k shares a day
Implied vol.43%near-the-money, 20-60 d
P/E25.6EPS 0.38
Dividend yieldnone
Beta1.04about the market
Next earnings4 Nov 2026in 19 days (after the close)

Is VMD undervalued?

Viemed Healthcare, Inc. (VMD) closed at 9.69 on 16 Oct 2026. The GLS average fair value - the simple average of the 8 valuation models that produced a positive number - is 14.75, which puts the price 34% below it. 4 of the 8 models value the shares above the current price. A gap this wide is rare in our universe of ~7,400 US stocks and is exactly what the Value part of the Wheel Score rewards; it is also where the question "why is it this cheap?" matters most.

There is a wide gap between DCF (0.1336) and Payback Time (30.27). When the models are this far apart the "fair value" is really a range, and the margin of safety above should be read with that range in mind.

The nightly engine files VMD under High Growth: revenue and earnings growing fast enough that the growth-based models carry the valuation.

Nine valuation models for VMD

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF0.1336-99%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number5.67-42%The most a defensive investor pays for the earnings and book value per share
Graham Growth21.68+124%Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields
Lynch9.48-2%EPS × the earnings growth rate (PEG of 1), growth capped at 25%
GLS Growth23.21+139%EPS compounded ten years at the blended growth rate, discounted back at 15% a year
10 Cap23.34+141%Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%
Payback Time30.27+212%Eight years of compounded free cash flow: the price at which the business pays for itself
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV4.21-57%Earnings power value: current EPS capitalised at 9% with no growth
Zombie (liquidation)-0.6020-106%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target14.00+44%Analysts' average 12-month price target. Not in the average

Quality and financial health

Viemed Healthcare, Inc. scores 6 of 9 on the Piotroski F-score: a middling result that passes the Sunday Scan's "6 or more" rule. Some of the nine tests on profitability, leverage and efficiency are failed, so the accounts are worth a look before selling a put on the name. On durability VMD scores 6.9/10 on the GLS Moat - a middle reading; the Scorecard on the Quote page's Financials tab shows which ten-year lines are steady and which are not.

Returns on capital are moderate - ROIC 9.5%, ROE 10.6%, ROA 6.9% - with debt at 0.11 times equity and a free-cash-flow yield of 7.9%.

Viemed Healthcare, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain. Revenue comes mainly from Equipment Sales 75%, Service 25% (quarter Q2 FY2026).

Institutional ownership scores 8/10, insider activity 1/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score6 / 9ROIC9.5%
GLS Moat6.9 / 10ROE10.6%
Debt / equity0.11ROA6.9%
Free-cash-flow yield7.9%Payout ratio0%
Institutions8 / 10Insiders · Congress1 · 5 / 10

Wheel Score 77: Good

With a Wheel Score of 77 - the Good band - Viemed Healthcare, Inc. clears the Sunday Scan's "70 or higher" rule. The parts: Value 25/25, Health 13/20, Moat 10/15, Premium 20/20, Stability 8/20; Stability (8/20) scores lowest.

Implied volatility is 43% on the near-the-money contracts 20-60 days out - inside the 35-60% range the Wheel Score pays full marks for: enough premium to be worth selling, not so much that the risk is unpaid. Chain open interest is thin - 614 contracts across every expiry - so fills at a fair price are not guaranteed; a 30-45-day put may not exist at a usable strike.

Volume runs at 219k shares a day on a market cap of $369M, with a beta of 1.04; the Stability part of the Wheel Score gives that 8 of 20.

PartPointsFrom
Value25 / 2534% margin of safety
Health13 / 20Piotroski 6/9
Moat10 / 15moat 6.9/10
Premium20 / 20implied volatility 43%
Stability8 / 20219k shares/day, $369M cap, beta 1.04

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls; it is updated nightly and is not a recommendation. The walkthrough lesson shows how the score fits into a trade, start to finish.

Upcoming events

The next earnings report is due on 4 Nov 2026 (after the close), 19 days away; a 30-45-day put sold today would expire after it, which is worth weighing against the premium.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Medical - Care Facilities

The 12 companies below are the closest to Viemed Healthcare, Inc. by market cap within the Medical - Care Facilities industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
SRTA
Strata Critical Medical, Inc.
4.2811.39+62%45Weak$379M
AUNA
Auna S.A.
5.3029.73+82%39No options$392M
CYH
Community Health Systems, Inc.
2.99154.27+98%45Weak$422M
AONC
American Oncology Network, Inc.
11.00--29No options$322M
GMRS
GMR Solutions Inc.
10.3926.59+61%38No options$561M
KJFI
Comjoyful International Company
0.9740--31No options$212M
STLN
Starling Oncology, Inc.
6.51--44Weak$651M
INNV
Innovage Holding Corp.
8.988.21-9%45Weak$1.2B
USPH
U.S. Physical Therapy, Inc.
84.9150.56-68%45Weak$1.3B
AIRS
AirSculpt Technologies, Inc.
1.42--36Weak$102M
NUTX
Nutex Health, Inc.
200.80732.07+73%39No options$1.4B
JYNT
The Joint Corp.
6.914.08-69%38Weak$98M

⚖ Compare VMD with 7 of them   All Healthcare stocks →

Screen the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the same eight-rule screen, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about VMD

Is VMD undervalued right now?

By the GLS models, yes: at 9.69 the stock is 34% below the average fair value of 14.75 (data as of 16 Oct 2026). Whether the discount is deserved is the question to research next.

What is the Wheel Score of VMD and what does it mean?

VMD scores 77 out of 100 (Good). The Wheel Score blends the margin of safety (25 points), Piotroski health (20), the GLS moat (15), the option premium on offer (20) and trading stability (20) into one number that ranks stocks for the wheel strategy - selling cash-secured puts, then covered calls if assigned. 80 and above is Prime, 65-79 Good, 50-64 Fair, under 50 Weak.

What is the GLS fair value for VMD?

14.75 per share as of 16 Oct 2026 - the simple average of the 8 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Viemed Healthcare, Inc. report earnings next?

The next earnings report is due on 4 Nov 2026 (after the close), 19 days from the data date of 16 Oct 2026. The Calendars page lists every upcoming report with its time of day.

Does VMD have listed options, and how liquid are they?

Yes. The nightly snapshot found 78 listed contracts with 614 open interest across all expiries and implied volatility of 43% on the near-the-money contracts. The Options scanner lists the cash-secured put and covered call set-ups with premium and annualised yield worked out.

Data as of 16 Oct 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.